Sign in

NCT05275231Completed

Better Together Study

Better Together: A Patient-centered Approach to Improve Diabetes Among Immigrant Communities

Source: ClinicalTrials.gov · Last updated 3 Mar 2025

Brief summary (registry, in English)

This study (Aim 1) seeks to test that a culturally-tailored lifestyle intervention is feasible and acceptable for immigrant men from South Asia and West Africa. This will be a pre-post pilot study of a 16-week lifestyle program for South Asians and West Africans with prediabetes or diabetes in Atlanta. Patients will participate in health-professional-led group visits every other week focused on improving dietary and exercise practices to reduce weight. Groups will be followed at baseline, 4 months and 12 months. Groups will be separated by region of origin (i.e. separate groups for South Asians and West Africans). For Aim 2,the study team will assess intervention spillover effects among participant's self-identified social networks. The study team will ask participants in Aim 1 to name 5 people in their social networks to participate in a survey of health behaviors at baseline and 12-months to assess health behavior practices.

Status (registry)
Completed
Study type
Interventional
Enrollment
108 (actual)
First submitted
31 Jan 2022
Start date
4 Apr 2022
Primary completion date
20 Nov 2023
Lead sponsor
Emory University
NCT number
NCT05275231

What you commit to

  • Study type: Interventional
  • Participants enrolled: 108
  • From 4 Apr 2022 to the primary completion date, 20 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Type 1 diabetes or diabetes secondary to other conditions (e.g. steroid-induced, pancreatic insufficiency, or chemotherapy-induced)
  • End-stage disease or serious illness that prohibits participation (e.g. end-stage renal disease or class IV congestive heart failure)

Age

  • Malignancy or life-threatening illness with life expectancy of \<5 years

Other

  • Inability to perform unsupervised physical activity
  • Diagnosed with cognitive deficits or limited decision-making capacity
  • Alcohol or substance abuse
  • Homelessness or no fixed address.

Who the study is looking for

  • Men \>18 years of age
  • Diagnosis of Type 2 Diabetes (T2D) (documented A1c of ≥ 5.7% or fasting blood glucose of \>100) or prediabetes
  • A family member or peer is willing to participate and attend all sessions as a social partner (if enrolling in dyad arm)
  • Proficiency in English(if in dyad, at least one member of each dyad)
  • Willingness to provide written consent
  • Proficient in English
  • Age greater than or equal to 18 years

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Emory Family Medicine Center
Coordinator of this site? Confirm its status
DunwoodyUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.